​
​

Ikena Oncology (IKNA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Ikena Oncology Revenue Highlights

Latest Revenue (Y)

$9.16M

0

Ikena Oncology Revenue by Period

Ikena Oncology Revenue by Year

DateRevenueChange
2023-12-31$9.16M-41.35%
2022-12-31$15.62M-49.59%
2021-12-31$30.98M237.01%
2020-12-31$9.19M-33.15%
2019-12-31$13.75M-

Ikena Oncology generated $9.16M in revenue during NA 2023, up -41.35% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Ikena Oncology Revenue by Quarter

DateRevenueChange
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$659.00K-44.39%
2023-09-30$1.19M-40.87%
2023-06-30$2.00M-62.28%
2023-03-31$5.31M-2.51%
2022-12-31$5.45M-14.87%
2022-09-30$6.40M1575.92%
2022-06-30$382.00K-88.71%
2022-03-31$3.38M-83.26%
2021-12-31$20.22M439.70%
2021-09-30$3.75M5.55%
2021-06-30$3.55M2.16%
2021-03-31$3.47M5244.62%
2020-12-31$65.00K-97.70%
2020-09-30$2.83M-7.94%
2020-06-30$3.07M-4.77%
2020-03-31$3.23M15.09%
2019-12-31$2.80M-

Ikena Oncology generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Ikena Oncology Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
KYMRKymera Therapeutics$78.59M$3.74M
NRIXNurix Therapeutics$76.99M$12.59M
FHTXFoghorn Therapeutics$34.16M$7.81M
HOWLWerewolf Therapeutics$19.94M$1.14M
IKNAIkena Oncology$9.16M-
STOKStoke Therapeutics$8.78M$4.89M
STTKShattuck Labs$1.66M$1.61M
MNOVMediciNova$1.00M-
ANEBAnebulo Pharmaceuticals--
DSGNDesign Therapeutics--
RZLTRezolute--
AVTEAerovate Therapeutics--
DBTXDecibel Therapeutics--
ELYMEliem Therapeutics--
CELCCelcuity--
GLUEMonte Rosa Therapeutics-$4.70M
EWTXEdgewise Therapeutics--
XLOXilio Therapeutics-$2.36M

IKNA Revenue FAQ

What is Ikena Oncology’s yearly revenue?

Ikena Oncology's yearly revenue for 2023 was $9.16M, representing a decrease of -41.35% compared to 2022. The company's yearly revenue for 2022 was $15.62M, representing a decrease of -49.59% compared to 2021. IKNA's yearly revenue for 2021 was $30.98M, representing an increase of 237.01% compared to 2020.

What is Ikena Oncology’s quarterly revenue?

Ikena Oncology's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a -100.00% decrease year-over-year (Q1 2023). IKNA's quarterly revenue for Q4 2023 was $659K, a -44.39% decrease from the previous quarter (Q3 2023), and a -87.91% decrease year-over-year (Q4 2022).

What is Ikena Oncology’s revenue growth rate?

Ikena Oncology's revenue growth rate for the last 3 years (2021-2023) was -70.44%, and for the last 5 years (2019-2023) was -33.40%.